Clinical Report: HPV Uptake Grows Over Time

Overview

A multicomponent intervention aimed at increasing HPV vaccination rates in pediatric primary care showed a growing effect over time, despite not achieving statistically significant differences at individual time points. The study highlights the importance of sustained system-level support for improving vaccination coverage.

Background

Human papillomavirus (HPV) vaccination is crucial for preventing multiple cancers, yet uptake remains below national targets in the U.S. This study evaluates a systems-focused intervention designed to enhance HPV vaccination initiation and completion rates among children by age 13. Understanding effective strategies for increasing vaccination rates is essential for public health.

Data Highlights

Key Findings

• The intervention group showed higher HPV vaccine initiation rates at 24 and 36 months compared to controls.
• Completion rates also improved in the intervention group, though not statistically significant after full adjustment.
• Clinicians in the intervention group reported increased use of announcement-style communication and higher self-efficacy in addressing parental hesitancy.
• COVID-19 pandemic disruptions affected the implementation of the intervention.
• Long-term evaluation periods may be necessary to demonstrate measurable improvements in vaccination rates.

Clinical Implications

Healthcare providers should consider implementing multicomponent strategies that include practice facilitation, clinician education, and communication training to improve HPV vaccination rates. Sustained support and evaluation are critical for achieving long-term improvements in vaccination coverage.

Conclusion

The study underscores the complexity of behavior change in vaccination practices and the potential for cumulative gains over time through structured interventions. Continued focus on system-level support is essential for enhancing HPV vaccination uptake.

References

1. Wang et al., JAMA Network Open, 2026 -- A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care: A Cluster Randomized Clinical Trial
2. The Journal of Infectious Diseases, 2023 -- Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence
3. The ASCO Post, 2024 -- HPV Screening Intervals for Cervical Cancer May Be Safely Extended Beyond Current 5-Year Recommendation, Study Finds
4. The ASCO Post, 2025 -- Cervical Precancer Incidence Decreases as HPV Vaccination Rates Rise
5. The ASCO Post — HPV Screening Intervals for Cervical Cancer May Be Safely Extended Beyond Current 5-Year Recommendation, Study Finds
6. Recommended Child and Adolescent Immunization Schedule
7. CDC data show uptick in some teen vaccine coverage | CIDRAP
8. A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care: A Cluster Randomized Clinical Trial | Pediatrics | JAMA Network Open | JAMA Network